Western officials say China is covertly building a naval facility in Cambodia - press (update)
- Officials say both countries deny the base is being built and are taking extraordinary measures to conceal the operation
Research Calls
- Upgrades:
- American Express (AXP) upgraded to Buy from Hold at Edward Jones
- American Software (AMSWA) upgraded to Buy from Neutral at B. Riley Securities; tgt $23
- Ardagh Metal Packaging S.A. (AMBP) upgraded to Overweight from Equal Weight at Barclays; tgt $9
- Aurora Cannabis (ACB) upgraded to Hold from Sell at Stifel
- CAE (CAE) upgraded to Neutral from Underperform at BofA Securities
- CrowdStrike (CRWD) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $215
- lululemon athletica (LULU) upgraded to Mkt Perform from Underperform at Bernstein; tgt $300
- ResMed (RMD) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $244
- Ryder System (R) upgraded to Peer Perform from Underperform at Wolfe Research
- Societe Generale (SCGLY) upgraded to Buy from Hold at Jefferies
- Spotify (SPOT) upgraded to Outperform from Mkt Perform at Raymond James; tgt $150
- Vallourec SA (VLOWY) upgraded to Equal Weight from Underweight at Barclays
- Downgrades:
- Dun & Bradstreet (DNB) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt raised to $18
- Edison (EIX) downgraded to Neutral from Buy at UBS; tgt lowered to $73
- L.B. Foster (FSTR) downgraded to Neutral from Buy at B. Riley Securities; tgt lowered to $14
- Others:
- American Tower (AMT) resumed with a Buy at BofA Securities; tgt $315
- Bausch + Lomb (BLCO) initiated with a Buy at Citigroup
- DoorDash (DASH) initiated with a Mkt Perform at Raymond James
- GoodRx (GDRX) resumed with a Buy at BofA Securities; tgt $11
- Grab (GRAB) initiated with a Buy at China Renaissance; tgt $4.20
- GXO Logistics (GXO) initiated with an Outperform at Cowen; tgt $64
- Hanover Bancorp (HNVR) initiated with an Overweight at Piper Sandler; tgt $26
- MercadoLibre (MELI) initiated with an Outperform at KGI Securities; tgt $1200
- Modiv (MDV) initiated with a Buy at Colliers Securities; tgt $22
- Regeneron Pharma (REGN) initiated with an Underperform at Jefferies; tgt $536
- Selecta Biosciences (SELB) initiated with an Outperform at SVB Leerink; tgt $7
- SEMRush (SEMR) initiated with an Equal-Weight at Morgan Stanley; tgt $13
- Volaris Aviation (VLRS) initiated with an Overweight at JP Morgan; tgt $23
![]()
Gapping down
News:
- VERA -2% (files for $400 mln mixed securities shelf offering)
- AREC -1.7% (files for $36.39 mln mixed securities shelf offering)
- H -0.7% (reports May update)
Analyst comments:
- DNB -0.9% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
Gapping up
In reaction to earnings/guidance:
- SAIC +6%, ODFL +0.7% (Q2 update)
Other news:
- ASPN +12.6% (provides FY22 business update)
- CSIQ +5.9% (sells 70% Stake in 738 MWp Solar Projects to SPIC Brasil)
- SAVE +4.6% (JetBlue Airways submits improved proposal to acquire Spirit Airlines)
- HUT +3.9% (reports 7078 self-mined Bitcoin in reserve after 309 were generated in May)
- TOI +3.1% (files for 1342076 share common stock offering by selling shareholders)
- TSLA +2.7% (Elon Musk tweets "Total headcount will increase but salaried should be fairly flat")
- ARQT +2.6% (topline results from STRATUM pivotal phase 3 trial of roflumilast foam 0.3%)
- PK +2.2% (provides operating trends in Q2 update)
- BCRX +2.2% (Health Canada has authorized ORLADEYO (berotralstat) as prevention of recurrent hereditary angioedema (HAE) attacks)
- VERU +2.1% (presentation of final positive phase 1b/2 clinical trial results for sabizabulin in metastatic castration resistant prostate cancer at the 2022 American Society of Clinical Oncology Annual Meeting)
- SBUX +1.9% (Board of Directors affirms CEO transition details; Board reiterates plans of driving toward naming new leader in Fall)
- EPR +1.6% (files mixed securities shelf offering)
- DNA +1.4% (acquired certain assets from Bitome)
- GSK +1.3% (receives FDA approval of Priorix for the prevention of measles mumps and rubella in individuals 12 months of age and older)
- ET +1.2% (signs LNG sale and purchase agreement with China Gas)
Analyst comments:
- SPOT +5% (upgraded to Outperform from Mkt Perform at Raymond James)
- AMSWA +3.9% (upgraded to Buy from Neutral at B. Riley Securities)
- AMBP +3.7% (upgraded to Overweight from Equal Weight at Barclays)
- CRWD +2.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- ACB +1.9% (upgraded to Hold from Sell at Stifel)
- AXP +1.4% (upgraded to Buy from Hold at Edward Jones)
- RMD +1.2% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- LULU +1.1% (upgraded to Mkt Perform from Underperform at Bernstein)
Early premarket gappers
- Gapping up:
- MRUS +5%, CARA +4.9%, TSLA +3.8%, PK +3.3%, TOI +3.1%, ACLX +2.4%, HOOK +2.4%, SHEL +1.9%, EPR +1.6%, SBUX +1.6%, LLY +1.4%, GSK +1.3%, ET +1.3%, BP +1.1%, BNTX +1%, GILD +0.7%, OXY +0.7%, COP +0.6%, XLE +0.5%, PSX +0.5%
- Gapping down:
- PBYI -2.1%, VERA -2%, STON -1.4%, JOAN -0.8%, AREC -0.6%